Lub tuam txhab Synthetic Biotechnology Amyris nthuav tawm kev nce qib hauv Cov Khoom Muag Khoom Muag

• Tsim tawm Amyris Inc. (Nasdaq: AMRS), ib lub tuam txhab hluavtaws biotechnology, tau ua tiav kev sib tham ntawm cov nyiaj txiag tseem ceeb thiab cov ntsiab lus lag luam rau qhov tshwj xeeb txoj cai muab ob yam ntawm nws cov khoom xyaw. Qhov kev lag luam muaj qhov xav tau ntau dua $ 500 lab.

• Ob tog tau pom zoo kom tsis pub lwm tus paub txog cov ntsiab lus ntxiv txog kev hloov pauv, uas yuav raug tshuaj xyuas los ntawm kev tsis ntseeg raws li Hart-Scott-Rodino Act (HSR) nrog rau lub sijhawm tos txog peb caug hnub.

• Amyris yuav txuas ntxiv txhim kho, ntsuas thiab tsim cov khoom xyaw. Tsis tas li ntawd, cov tog neeg xav tias yuav nkag mus rau R&D kev sib koom tes ntev ntev los tsim cov molecules tshiab.

• "Qhov no yog peb qhov kev hloov pauv thib peb ntawm qhov xwm txheej no thiab qhov peb ntseeg tias yog ib feem ntawm peb cov qauv kev lag luam rau kev tsim nqi ntawm peb cov thev naus laus zis," said CEO John Melo.

• Kev lag luam yuav tsum tau kos npe thiab kaw thaum ntxov hauv thawj peb lub hlis twg ntawm 2023.

• Nqe Nqis: AMRS shares tau ua lag luam qis dua 4.12% ntawm $ 1.86 ntawm daim tshev kawg hnub Tuesday.

• Duab Ntawm Tuam Txhab

Saib ntxiv ntawm Benzinga

Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.

© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.